ASX:ADO

AnteoTech Stock Forecast, Price & News

Add

Compare

Today's Range N/A

50-Day Range N/A

52-Week Range N/A

Volume1.43 million shs

Average VolumeN/A

Market CapitalizationN/A

P/E RatioN/A

Dividend YieldN/A

BetaN/A

Receive ADO News and Ratings via Email

Sign-up to receive the latest news and ratings for AnteoTech and its competitors with MarketBeat's FREE daily newsletter.

About AnteoTech

AnteoTech Limited engages in developing, commercializing, manufacturing, and distributing products for the life sciences research, vitro diagnostics, energy, and medical device markets primarily in Australia. Its principal technology products include AnteoCoat, which is applicable to the energy sector in lithium-ion batteries; AnteoBind that is applicable to point of care, in vitro, and life science diagnostic sectors. The company also manufactures and sells COVID-19 antigen testing kits. AnteoTech Limited has collaboration agreements with Axxin for for COVID-19 anigen test. The company was formerly known as Anteo Diagnostics Limited and changed its name to AnteoTech Limited in November 2019. AnteoTech Limited was incorporated in 1995 and is headquartered in Eight Mile Plains, Australia.

AnteoTech (ASX:ADO) share price lifts as Ellume US sales ramp-up
July 19, 2021 | msn.com

ANTEO TECH FPO (ADO.AX) stock forecast and price target
July 4, 2021 | finance.yahoo.com

Why is the AnteoTech share price racing higher?
May 24, 2021 | fool.com.au

Anteotech flags in-house scale up for its COVID-19 test kit, shares edge higher
May 24, 2021 | msn.com

Why the AnteoTech (ASX:ADO) share price is soaring 9% higher today
May 20, 2021 | fool.com.au

Last Orders: Tech and energy stocks help the ASX closer higher
May 17, 2021 | msn.com

The AnteoTech (ASX:ADO) share price is on watch. Here’s why.
April 28, 2021 | msn.com

ASX stock of the day: AnteoTech (ASX:ADO) shares top ASX
April 20, 2021 | msn.com

The Anteotech (ASX:ADO) share price is surging. Here’s why.
April 11, 2021 | msn.com

Last Orders: Sixth straight day of gains for small caps
April 9, 2021 | msn.com

See More Headlines

Industry, Sector and Symbol

Stock Exchange ASX
Industry Medical Devices
Sub-IndustryN/A
SectorMedical
Current SymbolASX:ADO
Previous Symbol
CUSIPN/A
CIKN/A
Webwww.anteodx.com
Phone61 7 3219 0085
EmployeesN/A
Year FoundedN/A

Sales & Book Value

Annual Sales$1.96 million
Price / Sales0.00
Cash FlowN/A
Price / Cash Flow22.00
Book ValueA$0.00 per share
Price / BookN/A

Profitability

Debt

Price-To-Earnings

Miscellaneous

Outstanding SharesN/A
Market CapN/A
Next Earnings DateN/A
OptionableNot Optionable

MarketRank^™

Overall MarketRank^™

1.05 out of 5 stars

0.0 Analyst's Opinion

Consensus Rating
There is not enough analysis data for AnteoTech.

3.6 Community Rank

Outperform Votes
AnteoTech has received 18 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
AnteoTech has received 7 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
AnteoTech has received 72.00% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about AnteoTech and other stocks. Vote “Outperform” if you believe ADO will outperform the S&P 500 over the long term. Vote “Underperform” if you believe ADO will underperform the S&P 500 over the long term. You may vote once every thirty days.

0.0 Dividend Strength

Dividend Yield
AnteoTech does not currently pay a dividend.
Dividend Growth
AnteoTech does not have a long track record of dividend growth.

1.7 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, AnteoTech insiders have bought more of their company's stock than they have sold. Specifically, they have bought A$4,516.00 in company stock and sold A$0.00 in company stock.

0.0 Earnings and Valuation

See Top Rated MarketRank™ Stocks Here

AnteoTech (ASX:ADO) Frequently Asked Questions

What stocks does MarketBeat like better than AnteoTech?

Wall Street analysts have given AnteoTech a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but AnteoTech wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How were AnteoTech's earnings last quarter?

AnteoTech Limited (ASX:ADO) released its quarterly earnings results on Wednesday, February, 27th. The company reported $0.00 EPS for the quarter.
View AnteoTech's earnings history.

Who are AnteoTech's key executives?

AnteoTech's management team includes the following people:

Mr. Derek Thomson, Chief Exec. Officer
Mr. Duncan Patrick Cornish A.C.A., ACA, CFO & Company Sec. (Age 54, Pay $116k)
Dr. N. Joe Maeji B.Sc., Ph.D., Founder & Chief Scientific Officer
Ms. Friederike Graser, Communications Mang.
Dr. Charlie Huang B.Sc., Ph.D., Head of Diagnostics & Life Science
Mr. Selahattin Guldu, Exec. VP of Commercial Banking
Mr. Manuel Wieser, Head of Energy

Who are some of AnteoTech's key competitors?

Some companies that are related to AnteoTech include 4DMedical (4DX), Adherium (ADR), ADM Tronics Unlimited (ADMT), Allegra Orthopaedics (AMT), Analytica (ALT), Anteris Technologies (AVR), Asensus Surgical (ASXC), Atomo Diagnostics (AT1), AVITA Medical (AVH), Azure Healthcare Limited (AZV.AX) (AZV), Cannabix Technologies (BLO), CleanSpace (CSX), Cochlear (COH), Cochlear (CHEOY) and Cochlear (CHEOF).
View all of ADO's competitors.

What other stocks do shareholders of AnteoTech own?

Based on aggregate information from My MarketBeat watchlists, some companies that other AnteoTech investors own include Mesoblast (MSB) and Evolution Mining (EVN).

What is AnteoTech's stock symbol?

AnteoTech trades on the ASX under the ticker symbol "ADO."

How much money does AnteoTech make?

AnteoTech has a market capitalization of $0.00 and generates $1.96 million in revenue each year.

What is AnteoTech's official website?

The official website for AnteoTech is www.anteodx.com.

How can I contact AnteoTech?

The company can be reached via phone at 61 7 3219 0085.

This page was last updated on 7/30/2021 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.